Abstract: The method of human prophylaxis comprising a number of steps is claim. First, the client is prepared for a steam bath, by applying a herbal paste on the skin, over at least one area of the client's body. The herbal paste is allowed to be absorbed into the client's body for an amount of time of at least five minutes and is followed with a massage the client's body. The client is then placed into a cedar steam barrel, connected to the steam generator, where the client's body is exposed to the steam. Following the stream procedure, the herbal paste is reapplied, the client's body is massaged, and the client to rests and drinks at least one cup of tea.

Abstract: The invention provides a method for producing a guava leaf extract powder, including extracting guava leaves with hot water at 90 to 98° C.; concentrating the obtained extract to a Brix level of 20 to 30; and lyophilizing the concentrated extract, and a guava leaf extract powder produced through the method which exhibits limited deterioration in quality after storage in solution for a long period of time.

Abstract: Method of selecting and preparing medical devices comprising extracts of plants and natural substances devoid of pharmacologically, immunologically or metabolically active fractions and characterised by a content of substances able to exert beneficial effects on the body, mediated by mechanical or physical effects, which said process comprises: a) removal by conventional processes of any pharmacologically, immunologically or metabolically active fractions from extracts of plants or natural substances; b) biological testing to establish that the extract or substance obtained in a) is devoid of pharmacological, metabolic and immunological effects; c) formulation of the extracts or substances that pass the test conducted at stage b) into suitable medical devices.

Abstract: The present invention relates to Curculigo latifolia (C. latifolia) extracts, wherein the extracts extracted from different parts of a plant such as fruits, roots and leaves, individually and in any combinations thereof, characterized in that the extracts are used as an agent for treating and preventing metabolic disorder diseases such as diabetes mellitus, obesity, cardiovascular, and atherosclerosis.

Abstract: Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids.

Abstract: Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with Morinda citrifolia and iridoids.

Abstract: Disclosed herein is synergistic herbal composition comprising extracts of herbal ingredients of Tribulus terrestris, Withania somnifera, Curculigo orchioides, Mucuna pruriens, Asparagus adscendens, Asteracantha longifolia, Asphaltum, and optionally the extracts of Piper longum and Anacyclus pyrethrum for the treatment of disorders associated with Male Sexual Dysfunction.

Abstract: Disclosed are compositions that include Docynia delavajy extract, Elaeagnus lanceolatus extract, or a combination of such extracts.

Abstract: A medicinal preparation, a process, a nutritional composition and regenerative and insulin potentiating method for humans and also for mammals for prevention, treatment and management/glycemic control of diabetes mellitus by obtaining optimum glucose level in blood, by administering an extract of Costus pictus to produce above effect in a dose of 500-2000 mg/day in humans and 50-200 mg/kg/day in rats. A method for treating hyperglycemia in a patient by administering a medicinal preparation of Costus pictus D. Don. A method for long term management of diabetes by avoiding the problems associated with tight control of blood glucose concentrations, i.e., hypoglycemia tolerance and seizures, while simultaneously avoiding the problems associated with conventional moderate control of blood glucose concentrations, i.e., pathological complications associated with hyperglycemia, such as nephropathy, retinopathy, etc.

Abstract: A method for the production of a plant-based medicament which contains Iberis amara, Menthae piperitae folium, Matricariae flos, Carvi fructus, Melissae folium, Angelicae radix, Liquiritiae radix, Cardui mariae fructus and Chelidonii herba in the form of alcoholic extracts and a medicament produced according to this method, and its use.

Abstract: An adhesive solid therapeutic composition containing an active ingredient which is an extract of a plant selected from the group consisting of Sambucus nigra, Centella asiatica and Echinacea purpurea, or mixtures thereof and excipients, said excipients comprising (i) a bulk ingredient (ii) an adhesive polymer of acrylic acid and (iii) polyyinylpyrrolidone.

Abstract: Some embodiments of the invention are directed to a pharmaceutical composition comprising an anti-inflammatory or an anti-hyperalgesic effective amount of isolated or purified Ipomomoea batatas trypsin inhibitor and a pharmaceutically acceptable carrier. The Ipomomoea batatas trypsin inhibitor may be derived from a sweet potato leaf or storage root. Also contemplated are methods of treating inflammation or hyperalgesia comprising selecting a subject suffering from inflammation or hyperalgesia, such as a subject with edema; and administering an anti-inflammatory or anti-hyperalgesia effective amount of amount Ipomomoea batatas trypsin inhibitor or a composition comprising an amount of Ipomomoea batatas trypsin inhibitor to the subject; wherein inflammation or hyperalgesia in the subject is reduced upon administration.

Abstract: The present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from Morinda citrifolia L. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.

Abstract: The present invention relates to the use of a composition made from Clerodendrum for treating tic disorder or sensorimotor gating deficits, wherein the composition is particularly made from the leaves of the plant.

Abstract: The invention relates to a cosmetic preparation which includes a skin care complex having an anti-ageing effect. The complex consists of liposomes comprising a mixture of cosmetic oil, extract of Plukenetia volubilis seeds, extract of Cynara scolymus leaves and hydrogenated retinol. The liposomes are homogeneously dispersed in a gel network consisting of water and a gel-forming agent.

Abstract: Xanthone compositions are provided herein. Formulations containing such compositions and methods of using such formulations and compositions are also provided. The present description additionally sets forth processes for making one or more compositions including compositions capable of promoting collagen production, antioxidant compositions, and anti-inflammatory compositions.

Abstract: The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of HIV, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from PPAR?2, LPL and ?P2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual.

Abstract: A new treatment for individuals suffering from type 2 diabetes. The formulation used in the treatment includes a mixture of a thiazoleineione, an insulin, cinnamon bark extract, and at least one synergistic supplement selected from the group consisting of blueberry leaf extract, cranberry extract, kelp extract, sugar sea beet extract, acerola berry extract; ginger root extract, black cherry extract, green tea extract, Irish moss extract, aloe vera extract, and Stevia leaf extract. The thiazoleineione is preferably pioglitazone. The insulin is preferably an Insulin Aspart of rDNA origin. It is preferred that the cinnamon bark extract and synergistic supplement be in the form of a liquid concentrate.

Abstract: The present invention relates to the use of plant extracts of Passiflora alata as an anti-inflammatory agent in cosmetic and pharmaceutical compositions. The present invention further relates to a process for obtaining a plant extract of Passiflora alata comprising the steps of submitting the leaves of the Passiflora alata plants to an extraction with water to obtain an aqueous extract and submitting the aqueous extract thus obtained to at least one elution with an aqueous solution of ethanol in a specific column and later drying of said extract by spray-drying.

Abstract: A non-toxic insect repellent concentrate formulation utilizing a plurality of all natural active components has been proven to be effective in repelling mosquitoes for periods of between six to eight weeks, with one application. The insect repellent concentrate formulation includes a plurality of natural essential oils comprising at least one emulsifying agent to maintain the oils in a stable solution. A pH conditioning agent may be added to assure the formulation is pH balanced for application to grass, plants, and trees, without detriment. The formulation may be provided as either a concentrate, or at dilutions ready for direct application, and may be applied by any of a variety of methods including broadcast spraying, boom applicators, misting systems, aerosol spray devices, etc.

Abstract: The present invention relates to a process for preparing an extract from ivy leaves which includes the active ingredient hederacoside C and ?-hederin, and to extracts prepared by this process. According to this there is initially provision of a first, ?-hederin-rich extract and subsequently provision of a second, hederacoside C-rich extract. In a last step, the two extracts are blended to give an extract which has an adjusted hederacoside C content and an adjusted ?-hederin content.

Abstract: A medicinal preparation, a process, a nutritional composition and regenerative and insulin potentiating method for humans and also for mammals for prevention, treatment and management/glycemic control of diabetes mellitus by obtaining optimum glucose level in blood, by administering an extract of Costus pictus to produce above effect in a dose of 500-2000 mg/day in humans and 50-200 mg/kg/day in rats. A method for treating hyperglycemia in a patient by administering a medicinal preparation of Costus pictus D. Don. A method for long term management of diabetes by avoiding the problems associated with tight control of blood glucose concentrations, i.e., hypoglycemia tolerance and seizures, while simultaneously avoiding the problems associated with conventional moderate control of blood glucose concentrations, i.e., pathological complications associated with hyperglycemia, such as nephropathy, retinopathy, etc.

Abstract: The present disclosure relates to methods and compositions for the topical sustained delivery of therapeutic agents. Topical application of compositions containing a muscle fasciculating agent result in the sustained release of any therapeutic agent contained within the composition. More particularly, topical application of such compositions to the outer surface of the eyelid of a patient results in increased absorption and sustained release of the therapeutic agent into the eyes or systemically.

Abstract: The present invention relates to the use of an extract of a Vernonia plant from Madagascar in cosmetics, pharmaceuticals and food supplements for improving the skin status, more specifically by strengthening the dermal-epidermal junction and/or by activating fibroblasts synthesis of dermis and extracellular matrix compounds.

Abstract: An extract of the orchid Vanda coerulea is used as cosmetic active agent for regulating the cell cycle in the skin to combat or delay the appearance of visible signs of skin aging or slow down the effects thereof. The extract is used in a cosmetic composition or in an anti-aging method for delaying the appearance of signs of skin aging or slowing down the effects thereof to maintain the firmness of the skin and tissues or restore a more radiant complexion to the skin or alternatively combat disorders of pigmentation related to skin aging.

Abstract: A composition is provided, containing an extract of a plant of the genus Hemerocallis as an active ingredient and having antidepressant-like effects or fatigue-relieving effects based on sleep improvement. A composition is also provided, containing a hot-water extract of a plant of the genus Hemerocallis as an active ingredient and having antidepressant-like effects or fatigue-relieving effects based on sleep improvement.

Abstract: A herbal paint mixture comprising, in combination, a carrier paint having a first volume and an herbal mixture having a second volume. The first volume and the second volume being mixed together.

Abstract: An herbal composition for providing a beneficial effect to the respiratory tract. The composition includes Colt's Foot, Mangosteen, Thyme Leaf, Wild Cherry Bark, Quercitin, Sundew, Butterbur, and Grape Seed Extract. In particular, the composition may prevent or treat cough. Also described are methods of using the herbal composition.

Abstract: Compositions for the treatment of the affections of the oral cavity and upper respiratory tract include anthocyanosides, procyanidins and phloroglucinols. The anthocyanosides are derived from Vaccinium myrtillus extract, the procyanidins are derived from a Vitus vinifera extract, a Camellia sinensis extract or from other edible plants containing procyanidins, and the phloroglucinols are derived from Hypericum spp., Myrtus spp. or Humulus lupulus extracts.

Abstract: A method for treating cancerous or pre-cancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto is described herein.

Abstract: The invention relates to a cosmetic composition with a moisture-regulating effect based on plant active ingredients with a long-lasting moisturizing effect of up to 24 hours. The cosmetic comprises in each case a watery plant milk of the fruit of Elaeis guinensis, of the leaves of Phoenix canariensis, of the rice husks of Oryza sativa, of the fruit of Cocos nucifera, and a honey complex consisting of acacia honey, eucalyptus honey, pine honey and lavender honey.

Abstract: The invention of the present application provides a natural material derived from Swinglea glutinosa leaves that in combination with low doses of pyrethroids, maintains the effect of high doses of pyrethroids over mites. The material derived from Swinglea glutinosa leaves, in a preparation with pyrethroids, results in a mix material with the potential to lower the doses of synthetic pyrethroids, eliminating the need to use high doses of synthetic pesticides for acari control.

Abstract: Disclosed are compositions and corresponding methods of their use that include Nymphaea gigantea, Syzygium moorei, Cupaniopsis anacardioides, Archidendron hendersonii, Tristaniopsis laurina, Brachychiton acerifolius, Stenocarpus sinuatus, Alphitonia excelsa, Eucalyptus coolabah, Plumeria alba, Cocos nucifera, or Tamarindus indica extract.

Abstract: A composition and a method of using the composition is described that is effective to protect or repair oxidative damage to DNA in mammalian skin by up regulating each of SIRT1, Gadd45b, and SOD2. The composition includes at least two of a candle bush extract, noni leaf extract, and melon extract with each present in an amount such that the composition is effective to up regulate each of SIRT1, Gadd45b, and SOD2.

Abstract: The present invention relates to a composition for treatment and prevention of cardiovascular diseases, containing an extract of Lindera obtusiloba. More particularly, the extract of Lindera obtusiloba strongly inhibits NAD(P)H oxidases, which are the main cause of vascular diseases, and at the same time, regulates contraction and relaxation of vascular smooth muscles to manifest a potent vasorelaxant effect, thereby improving the blood pressure regulation and vascular endothelial dysfunction. Therefore, a composition containing this as an active ingredient can be usefully utilized as a pharmaceutical product or health functional food product for the prevention and treatment of cardiovascular diseases.

Abstract: An insect repellent fabric. The fabric comprises a fabric base and an active insect repellent ingredient. The active ingredient is contained within microcapsules and the fabric base is impregnated with the microcapsules. The preferred active ingredient is a Citronella extract or DEET.

Abstract: An anti-aging composition comprising a skin-beneficial amount of actives identified in Menyanthes trifoliata leaf, wherein the actives are inhibitors of one or more of MMP-1, 2 and 9 and/or scavengers of peroxynitrite. Also disclosed are methods of using such a composition, which include treating the skin for signs of chronological or pre-mature aging.

Abstract: A natural pharmaceutical preparation for treating hypoproteinemia, includes at least one member selected from the group consisting of a drug of increasing human serum albium, a drug of improving and enhance immunity, a drug of treating hepatitis B, a drug of treating Hepatitis C, a drug of treating acquired immune deficiency syndrome (AIDS), a drug of treating Tuberculosis, a drug of treat Fibrosis, a drug of treating hydrothorax, a drug of easing pain, a drug of stopping diarrhea, a drug of arresting coughing, a drug of reducing inflammation, and a drug of increasing urine.

Abstract: The invention of the present application provides a natural material derived from Swinglea glutinosa leaves that in combination with avermectins, increases the effect of avermectins over mites. The material derived from Swinglea glutinosa leaves, in a preparation with avermectins, results in an all natural material with the potential to replace combinations of avermectins with synthetic pyrethroids, eliminating the need to use synthetic pesticides for acari control.

Abstract: A kit including a first composition comprising leaves of Melissa officinalis, or parts thereof; a second composition comprising Eleutherococcus senticosus, or parts thereof; a third composition comprising Avena sativa, or parts thereof; a fourth composition comprising Ballota nigra, or parts thereof; a third composition comprising the roots of Glycyrrhiza glabra/gan cao, or parts thereof; and a sixth composition comprising roots of Uncaria tomentosa, or parts thereof. The invention further relates to a kit for use as a medicament, to a kit for use in the treatment of disorders in mammals, like humans, horses, cows, pigs and pets, to a kit for use in the treatment of lupus, multiple sclerosis, rheumatoid arthritis, rheumatism, osteoporosis, asthma in humans or tale and mane eczema in horses, and to the use of the kit for the treatment of lupus, multiple sclerosis, rheumatoid arthritis, rheumatism, osteoporosis, asthma in humans or tale and mane eczema in horses.

Abstract: Disclosed are powders or extracts of plant leaves with anti-obesity effects and anti-obesity foods comprising them, and more particularly, anti-obesity food compositions comprising powders or extracts of one or more selected from group consisting of persimmon (Diospyros KakI Thunb.) leaves, buckwheat (Fagopyrum esculentum) leaves, Chinese matrimony vine (Lycium chinense) leaves, endive (Cichorium endivia) leaves, and ginseng (Panax ginseng). Also disclosed are compositions comprising plant extracts or powders to reduce the weight of animals or humans, and more particularly, boiling water extracts of persimmon leaves, buckwheat leaves and Chinese matrimony vine leaves and persimmon leaf powder, buckwheat leaf powder and Chinese matrimony vine leaf powder were prepared and administered to animals or humans to confirm the effects of reduction of their weight and then health foods comprising the extracts or powders are produced.

Abstract: A pharmaceutical composition for the treatment of colds and influenza. The pharmaceutical composition is a mixture of: acetaminophen, diphenhydramine, dextromethorphan, arabinogalactan, vitamin C, zinc, olive leaf extract, resveratrol and elderberry extract.

Abstract: Cosmetic or dermatological compositions contain an orchid extract obtained from at least a part of the species Vanda teres. These compositions and extracts are used as a cosmetic or dermatological agent for maintaining the structure of the skin, in particular by limiting the degradation of the extracellular matrix of the upper layers of the dermis and of the epidermis, and/or for reducing or delaying the effects of skin ageing, in particular the formation of wrinkles, and/or for obtaining a protective, corrective or restructuring effect on the skin, and/or as an anti-inflammatory agent. A method of cosmetic care for the skin is particularly intended for obtaining an effect of prevention or slowing down of the appearance of skin ageing signs.

Abstract: The invention of the present application provides a natural material derived from Swinglea glutinosa leaves that alone or in combination with copper sulfate is as good or better than pesticide combinations for controlling Botrytis cinerea bunch rot of grapes, and sour rot of grapes caused by Alternaria sp., Cladosporium sp., Aspergillus sp., Mucor sp., Rhizopus sp., and Penicilium sp. The material derived from Swinglea glutinosa leaves, by itself, has better results than any of the pesticide combinations for controlling both, sour rot and bunch rot. A preparation of the material derived from Swinglea glutinosa leaves in combination with copper sulfate is better than pesticide combinations for sour rot of grapes, and a very good alternative, instead of pesticide combinations, for Botrytis cinerea bunch rot of grapes.

Abstract: A composition and method for the prevention and therapeutic treatment of skin conditions and disorders are disclosed. The composition and method of the invention are particularly directed to the treatment and prevention of dermal irritations. These irritations include, for example, psoriasis, eczema, ichthyosis, pruritus, dryness and dermatitis, which may cause skin to crack, chap or chafe. The composition and method are particularly useful in treating and preventing diaper dermatitis. A therapeutic composition according to the invention includes an agent, which is an enzyme constituent, promoting the synthesis of collagen and the reproduction of cells, particularly skin cells. Such therapeutic agents include, for example, zinc oxide. This agent is generally nonprescription and capable of effectively preventing and treating diaper dermatitis through local or topical application.

Abstract: A method of preparation of a potential herbal anti-cancer medicine from the leaves and twigs of Calotropis gigantean for prevention and treatment of all types of cancers, using fresh extract of leaves and twigs of Calotropis gigantea fortified with unrefined sugarcane sugar (jaggery). The aqueous extract of leaves and twigs of Calotropis gigantea was desiccated. The [3 H]-Thymidine growth assay was performed against cancer cell lines, WM 902-B and WM1341-D. The extract [28 mgms] was dissolved in 2 ml control at 0.5%, 0.1% DMSO. The extract is highly inhibitory at all dilutions and highly inhibitory to both the cancer cell lines.

Abstract: There is disclosed a topical composition and method for preventing and/or ameliorating the effects of aging on skin to improve the aesthetic appearance of skin and/or scalp. The invention utilizes the topical application of Amomum melegueta extract.

Abstract: The present invention discloses emulsified wax compositions having a wide range of uses, including as cosmetic, pharmaceutical and agricultural compositions, particularly for improving skin moisture, appearance, and wound healing, for the treatment of inflammation and allergic responses of the skin, and for preservation of agricultural fresh produce. The composition of the invention comprises an aqueous phase and at least one wax at a concentration of at least 5%, at least one fatty acid and at least one basic amino acid or a salt thereof.

Abstract: The present invention relates to compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes or metabolic syndrome containing extracts of Glycine max leaves or fractions isolated from the same.

Abstract: The use of plants or volatile oils thereof containing high d-Limonene in manufacturing medicaments for treatment of diabetes including type 2 diabetes and type 1 diabetes. Natural products above, as parent plants of d-Limonene, have effect to reduce blood glucose as strong as compound d-Limonene.